JPMorgan raised the firm’s price target on Alignment Healthcare (ALHC) to $18 from $17 and keeps a Neutral rating on the shares. The firm updated the company’s model.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALHC:
- Alignment Healthcare price target raised to $18.50 from $17 at TD Cowen
- Alignment Healthcare’s Earnings Call Highlights Strong Growth
- Strong Buy Rating Backed by Consistent EBITDA Growth and Strategic Expansion
- Alignment Healthcare price target raised to $18 from $13 at Barclays
- Alignment Healthcare price target raised to $18 from $17 at UBS